Search

everythinglearnresearchcommunity

for

Search:↓

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Tick bites can cause hair loss similar to alopecia areata, and baricitinib may help regrow hair.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

JAK inhibitors may reduce depression in people with alopecia areata.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Janus kinase inhibitors may help treat lichen planopilaris.

Topical Ruxolitinib may safely treat severe hair loss.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.